|
1
|
Lamoureux F, Trichet V, Chipoy C,
Blanchard F, Gouin F and Redini F: Recent advances in the
management of osteosarcoma and forthcoming therapeutic strategies.
Expert Rev Anticancer Ther. 7:169–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Z, He R, Xia H, Wei YU and Wu S:
MicroRNA-101 has a suppressive role in osteosarcoma cells through
the targeting of c-FOS. Exp Ther Med. 11:1293–1299. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo J, Reddick WE, Glass JO, Ji Q, Billups
CA, Wu J, Hoffer FA, Kaste SC, Jenkins JJ, Ortega Flores XC, et al:
Dynamic contrast-enhanced magnetic resonance imaging as a
prognostic factor in predicting event-free and overall survival in
pediatric patients with osteosarcoma. Cancer. 118:3776–3785. 2012.
View Article : Google Scholar
|
|
5
|
El-Naggar AM, Veinotte CJ, Cheng H,
Grunewald TG, Negri GL, Somasekharan SP, Corkery DP, Tirode F,
Mathers J, Khan D, et al: Translational Activation of HIF1α by YB-1
Promotes Sarcoma Metastasis. Cancer Cell. 27:682–697. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kansara M, Teng MW, Smyth MJ and Thomas
DM: Translational biology of osteosarcoma. Nat Rev Cancer.
14:722–735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, Function and Role in Cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar
|
|
8
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JG, Guo J-F, Liu D-L, Liu Q and Wang
J-J: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: MiR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma Y, Zhang P, Wang F, Zhang H, Yang J,
Peng J, Liu W and Qin H: miR-150 as a potential biomarker
associated with prognosis and therapeutic outcome in colorectal
cancer. Gut. 61:1447–1453. 2012. View Article : Google Scholar
|
|
15
|
Farhana L, Dawson MI, Murshed F, Das JK,
Rishi AK and Fontana JA: Upregulation of miR-150* and miR-630
induces apoptosis in pancreatic cancer cells by targeting IGF-1R.
PLoS One. 8:e610152013. View Article : Google Scholar
|
|
16
|
Hu H, Zhang Y, Cai XH, Huang JF and Cai L:
Changes in microRNA expression in the MG-63 osteosarcoma cell line
compared with osteoblasts. Oncol Lett. 4:1037–1042. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aguda BD, Kim Y, Piper-Hunter MG, Friedman
A and Marsh CB: MicroRNA regulation of a cancer network:
Consequences of the feedback loops involving miR-17-92, E2F, and
Myc. Proc Natl Acad Sci USA. 105:19678–19683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI
|
|
20
|
Jin J, Chu Z, Ma P, Meng Y and Yang Y:
Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion
by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
Tumour Biol. 39:10104283177162502017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li CY, Pang YY, Yang H, Li J, Lu HX, Wang
HL, Mo WJ, Huang LS, Feng ZB and Chen G: Identification of
miR-101-3p targets and functional features based on bioinformatics,
meta-analysis and experimental verification in hepatocellular
carcinoma. Am J Transl Res. 9:2088–2105. 2017.PubMed/NCBI
|
|
22
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-101 inhibits proliferation, migration and invasion in
osteosarcoma cells by targeting ROCK1. Am J Cancer Res. 7:88–97.
2017.PubMed/NCBI
|
|
23
|
Chang Z, Huo L, Li K, Wu Y and Hu Z:
Blocked autophagy by miR-101 enhances osteosarcoma cell
chemosensitivity in vitro. ScientificWorldJournal. 2014:7947562014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang K, Zhang Y, Ren K, Zhao G, Yan K and
Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by
downregulation of EZH2 expression. Oncol Rep. 32:2143–2149. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin S, Shao NN, Fan L, Ma XC, Pu FF and
Shao ZW: Effect of microRNA-101 on proliferation and apoptosis of
human osteosarcoma cells by targeting mTOR. J Huazhong Univ Sci
Technolog Med Sci. 34:889–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar
|
|
28
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang Y and Fullwood MJ: Roles, Functions,
and Mechanisms of Long Non-coding RNAs in Cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mouraviev V, Lee B, Patel V, Albala D,
Johansen TE, Partin A, Ross A and Perera RJ: Clinical prospects of
long noncoding RNAs as novel biomarkers and therapeutic targets in
prostate cancer. Prostate Cancer Prostatic Dis. 19:14–20. 2016.
View Article : Google Scholar
|
|
31
|
Liu X, Choy E, Hornicek FJ, Yang S, Yang
C, Harmon D, Mankin H and Duan Z: ROCK1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Villalonga P, Fernández de Mattos S and
Ridley AJ: RhoE inhibits 4E-BP1 phosphorylation and eIF4E function
impairing cap-dependent translation. J Biol Chem. 284:35287–35296.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Whatcott CJ, Ng S, Barrett MT, Hostetter
G, Von Hoff DD and Han H: Inhibition of ROCK1 kinase modulates both
tumor cells and stromal fibroblasts in pancreatic cancer. PLoS One.
12:e01838712017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maskey N, Li D, Xu H, Song H, Wu C, Hua K,
Song J and Fang L: MicroRNA-340 inhibits invasion and metastasis by
downregulating ROCK1 in breast cancer cells. Oncol Lett.
14:2261–2267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
36
|
Wang Y, Liang T, Wang Y, Huang Y and Li Y:
Long non-coding RNA AK093407 promotes proliferation and inhibits
apoptosis of human osteosarcoma cells via STAT3 activation. Am J
Cancer Res. 7:892–902. 2017.PubMed/NCBI
|
|
37
|
Jiang Z, Jiang C and Fang J: Up-regulated
lnc-SNHG1 contributes to osteosarcoma progression through
sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin
pathway. Biochem Biophys Res Commun. 495:238–245. 2018. View Article : Google Scholar
|
|
38
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.
|
|
39
|
Li HJ, Li X, Pang H, Pan JJ, Xie XJ and
Chen W: Long non-coding RNA UCA1 promotes glutamine metabolism by
targeting miR-16 in human bladder cancer. Jpn J Clin Oncol.
45:1055–1063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
